Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breviscapine dripping pills versus ginkgo leaf tablets for ischemic stroke recovery
ChiCTR2300067750Phase 4Not yet recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Dengzhanxixin and ginkgo biloba extract in ischemic stroke (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoint: Modified Rankin Scale. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
Dengzhanxixinginkgo biloba extract
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2300067750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067750.